Cargando…

c-Met signaling promotes IL-6-induced myeloma cell proliferation

OBJECTIVES: Hepatocyte growth factor (HGF) is a constituent of the myeloma microenvironment and is elevated in sera from myeloma patients compared to healthy individuals. Increased levels of serum HGF predict a poor prognosis. It has previously been shown by us and others HGF can act as a growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hov, Håkon, Tian, Erming, Holien, Toril, Holt, Randi Utne, Våtsveen, Thea K, Fagerli, Unn-Merete, Waage, Anders, Børset, Magne, Sundan, Anders
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704927/ https://www.ncbi.nlm.nih.gov/pubmed/19187270 http://dx.doi.org/10.1111/j.1600-0609.2009.01212.x

Ejemplares similares

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
por: Brenne, Anne-Tove, et al.
Publicado: (2009)

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients
por: Rampa, Christoph, et al.
Publicado: (2014)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells
por: Müller, Rebekka, et al.
Publicado: (2013)

Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma
por: Wader, K F, et al.
Publicado: (2008)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
por: Hjort, Magnus Aassved, et al.
Publicado: (2018)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
por: Sponaas, Anne Marit, et al.
Publicado: (2021)

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients
por: Sponaas, Anne-Marit, et al.
Publicado: (2018)

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015)

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
por: Slørdahl, Tobias S., et al.
Publicado: (2016)

The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
por: Sponaas, Anne M, et al.
Publicado: (2015)

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
por: Olsen, O E, et al.
Publicado: (2014)

TGF-β contamination of purified recombinant GDF15
por: Olsen, Oddrun Elise, et al.
Publicado: (2017)

FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
por: Quist-Løkken, Ingrid, et al.
Publicado: (2023)

Artesunate shows potent anti-tumor activity in B-cell lymphoma
por: Våtsveen, Thea Kristin, et al.
Publicado: (2018)

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
por: Giliberto, Mariaserena, et al.
Publicado: (2022)

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
por: Starheim, K K, et al.
Publicado: (2016)

Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas
por: Fevang, Børre, et al.
Publicado: (2018)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
por: Yang, Rui, et al.
Publicado: (2020)

Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
por: Vandsemb, Esten N., et al.
Publicado: (2016)

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone
por: Westhrin, Marita, et al.
Publicado: (2019)

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
por: Hernæs, Kjersti Helene, et al.
Publicado: (2021)

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
por: Steiro, Ida, et al.
Publicado: (2022)

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™
por: Tangen, Jon-Magnus, et al.
Publicado: (2017)

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
por: Misund, Kristine, et al.
Publicado: (2022)

A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model
por: Follin-Arbelet, Virginie, et al.
Publicado: (2011)

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
por: Rustad, E H, et al.
Publicado: (2015)

Targeting phosphoglycerate dehydrogenase in multiple myeloma
por: Elsaadi, Samah, et al.
Publicado: (2021)

Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells
por: Mahammad, Nur, et al.
Publicado: (2021)

Compartmentalization of TNF and IL-6 in meningitis and septic shock
por: Waage, Anders, et al.
Publicado: (1993)

Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study
por: Langseth, Øystein O., et al.
Publicado: (2022)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5fmk3foqtl5a42qbui9idhtqj